HER2 tumorigenic signaling also appears to be potentiated by a stable interaction via one of two EGF-like domains with the transmembrane mucin glycoprotein Muc4, known to frequently display an altered expression in many cancer types, thus promoting tumor cell proliferation and metastasis[152,153]. The gene discussed is ERBB2; the disease is neoplasm.